The present disclosure relates generally to pulse oximetry and, more particularly to switching photodetector sensor output filtering in an oximeter.
This section is intended to introduce the reader to various aspects of art that may be related to various aspects of the present invention, which are described and/or claimed below. This discussion is believed to be helpful in providing the reader with background information to facilitate a better understanding of the various aspects of the present invention. Accordingly, it should be understood that these statements are to be read in this light, and not as admissions of prior art.
Pulse oximetry is a non-invasive method of monitoring the percentage of hemoglobin (hereinafter “Hb”) that is saturated with oxygen. A pulse oximeter may include of a pheripheral probe linked to a monitor that may be microprocessor controlled. The probe may be placed on a peripheral part of the body such as a digit (e.g., one finger or toe), ear lobe or nose. Within the probe, there are typically two light emitting diodes (LEDs), one in the visible red spectrum (e.g., 660 nm) and the other in the infrared spectrum (e.g., 940 nm). Using a transmission type sensor, these two beams of light pass through tissue to a photodetector. During passage through tissue, some light is absorbed by blood and soft tissue depending on the concentration of Hb. The amount of light absorption at each light wavelength depends on the degree of oxygenation of Hb within the tissue. By calculating the light absorption at the two wavelengths, the microprocessor of the monitor may compute the proportion of oxygenated Hb. A microprocessor of an oximeter may average oxygen saturation values over five to twenty seconds. The pulse rate may also be calculated from the number of LED cycles between successive pulsatile signals and averaged over a similar variable period of time, depending on the particular oximeter. A monitor may display the percentage of oxygen saturated Hb together with an audible signal for each pulse beat, a calculated heart rate, and in some monitors, a graphical display of the blood flow past the probe. User programmable audible alarms may also be provided.
From the proportions of light absorbed at each light wavelength, the microprocessor may calculate an estimation of the patient's SpO2 level. The monitor may then display the oxygen saturation digitally as a percentage and/or audibly as a tone of varying pitch.
Reflection pulse oximetry uses reflected, rather than transmitted, light on a single-sided sensor. It can therefore be used proximally anatomically, e.g., on the forehead or bowel, although it may be difficult to secure. Other than using specific reflection spectra, the principles are generally the same as for transmission oximetry.
Oximeters may be calibrated during manufacture and may automatically check internal circuits when turned on. Oximeters may be accurate in the range of oxygen saturations of about 70% to 100% (+/ −2%), but may be less accurate under 70%. The pitch of the audible pulse signal may fall in reducing values of saturation. The size of the pulse wave (related to flow) may be displayed graphically. Some models automatically increase the gain of the display when the flow decreases, but in these models, the display may prove misleading. The alarms usually respond to a slow or fast pulse rate or an oxygen saturation below 90%. At this level, there may be a 30 marked fall in PaO2 representing serious hypoxia.
Certain aspects commensurate in scope with the originally claimed invention are set forth below. It should be understood that these aspects are presented merely to provide the reader with a brief summary of certain forms the invention might take and that these aspects are not intended to limit the scope of the invention. Indeed, the invention may encompass a variety of aspects that may not be set forth below.
According to a specific example embodiment of this disclosure, an apparatus for switchover of a pulse oximetry sensor may comprise: a pulse oximetry sensor; a first gain controlled amplifier having an input coupled to the pulse oximetry sensor; a digital filter having an analog input coupled to the pulse oximetry sensor; a second gain controlled amplifier having an input coupled to an analog output of the digital filter; a first voltage-to-current converter having a voltage input coupled to an output of the first gain controlled amplifier; a second voltage-to-current converter having a voltage input coupled to an output of the second gain controlled amplifier; the first and second voltage-to-current converters having outputs coupled together to produce a single current output; and a controller having a first gain control output coupled to the first gain controlled amplifier and a second gain control output coupled to the second gain controlled amplifier, wherein the controller may increase the gain of one of the gain controlled amplifiers over a period of time while decreasing the gain of the other gain controlled amplifier over the same period of time, so that the single current output from the first and second voltage-to-current converters represents the output of the gain controlled amplifier having the highest gain.
According to another specific example embodiment of this disclosure, a method of manufacturing a pulse oximeter may comprise providing a first gain controlled amplifier to which a pulse oximetry sensor may be coupled; coupling the pulse oximetry sensor to a digital filter; coupling the digital filter to a second gain controlled amplifier; coupling the first gain controlled amplifier to a first voltage-to-current converter; coupling the second gain controlled amplifier to a second voltage-to-current converter; and coupling the first and second voltage-to-current converter outputs together to produce a current output wherein the gain of one of the gain controlled amplifiers is adapted to increase over a period of time while the gain of the other gain controlled amplifier is adapted to decrease over the same period of time so that the current output from the first and second voltage-to-current converters represents the gain controlled amplifier having the highest gain.
According to yet another specific example embodiment of this disclosure, a pulse oximeter system having a switchover between unfiltered and filtered channels coupled to a pulse oximetry sensor may comprise: a pulse oximetry sensor; an unfiltered channel comprising a first gain controlled amplifier having an input coupled to the pulse oximetry sensor, and a first voltage-to-current converter having a voltage input coupled to an output of the first gain controlled amplifier; a filtered channel comprising a digital filter having an analog input coupled to the pulse oximetry sensor, a second gain controlled amplifier having an input coupled to an analog output of the digital filter, and a second voltage-to-current converter having a voltage input coupled to an output of the second gain controlled amplifier; the first and second voltage-to-current converters having outputs coupled together to produce a single current output; and a controller having a first gain control output coupled to the first gain controlled amplifier and a second gain control output coupled to the second gain controlled amplifier, wherein when the unfiltered channel is selected the controller may increase the gain of the first gain controlled amplifier over a period of time while decreasing the gain of the second gain controlled amplifier over the same period of time so that the single current output from the first and second voltage-to-current converters represents an unfiltered and amplified signal from the pulse oximetry sensor; and when the filtered channel is selected the controller may increase the gain of the second gain controlled amplifier over a period of time while decreasing the gain of the first gain controlled amplifier over the same period of time so that the single current output from the first and second voltage-to-current converters represents a filtered and amplified signal from the pulse oximetry sensor.
A more complete understanding of the present disclosure may be acquired by referring to the following description taken in conjunction with the accompanying drawings wherein:
While the present disclosure is susceptible to various modifications and alternative forms, specific example embodiments thereof have been shown in the drawings and are herein described in detail. It should be understood, however, that the description herein of specific example embodiments is not intended to limit the disclosure to the particular forms disclosed herein, but on the contrary, this disclosure is to cover all modifications and equivalents as defined by the appended claims.
During testing or use of oximeters, a need exists for an improved method to switch between photodetectors and/or different signal processing paths of a photodetector. Heretofore known switching between photo detectors and/or different signal processing paths of a photodetector has introduced undesirable signal transients that may set off oximeter monitor alarms and/or require longer periods of time for the transient to settle out of the normal five to twenty seconds averaging performed by a microprocessor of an oximeter monitor.
Accordingly, there is a need for improved methods, materials, and/or equipment to switch between photo detectors and/or different signal processing paths of a photo detector, e.g., unfiltered and filtered channels of a pulse oximetry sensor.
Referring now to the drawings, the details of specific example embodiments are schematically illustrated. Like elements in the drawings are represented by like numbers, and similar elements are represented by like numbers with a different lower case letter suffix.
Referring to
For example, at the beginning of a time period T, gain control signal line 106 has a control voltage 104 at a maximum V1 thereby setting the gain of gain controlled amplifier 114 to a maximum. As the time period T proceeds, control voltage 104 decreases until it is at a minimum V1, thereby reducing the gain of gain controlled amplifier 114. In a similar, but opposite fashion, gain control signal line 112 has a control voltage 110 that starts at the beginning of the time period T at a minimum V2 which may set the gain of gain controlled amplifier 116 to a minimum, and as the time period T proceeds, control voltage 110 increases until it is at a maximum V2, thereby, according to an embodiment, increasing the gain of gain controlled amplifier 116. Output current 126, according to an embodiment, represents the dominate gain controlled amplifier output signal 118 or 120, e.g., the one having the highest gain and signal input will block the other one. Thus, input signal transfer may switch from one of the input channels to the other without introducing a transient in the output current signal 126.
Referring to
The output of analog-to-digital converter 226 may be coupled to a digital filter 224 that may be used to enhance the signal information from the photo-detector 232. A digital-to-analog converter 222 may be coupled to the output of a digital filter 224 so as to convert this output to an analog voltage that may be coupled to an input of gain controlled amplifier 116. According to this specific example embodiment, the photodetector 232 may have an output that may be coupled directly (or indirectly) to the input of the gain controlled amplifier 114. In addition, the output of the photodetector 232 may be coupled (e.g., indirectly) to the gain controlled amplifier 116 through the digital filter 224. This particular embodiment is directed, in one aspect, to providing a switchover between signal line 102 having the unprocessed information from the photodetector 232 and the signal line 108 having the digitally filtered (enhanced) information from the photodetector 232.
The controller 216, e.g., a digital processor, a microprocessor, a microcontroller, a digital signal processor (DSP), an application specific integrated circuit (ASIC) and/or programmable logic array (PLA), in combination with digital-to-analog converters 218 and 220 may be used for controlling gains of the gain controlled amplifiers 114 and 116. When a selection change, e.g., nurse or doctor initiated, is made between the unfiltered and filtered signal information from the photodetector 232, the gain control signal line 106 may have a control signal from the digital-to-analog converter 220 that is at a maximum voltage at the beginning of a time period T, thereby, according to this embodiment, setting the gain of the gain controlled amplifier 114 to a maximum. As the time period T proceeds, the control signal on the gain control signal line 106 decreases until it is at a minimum, thereby, according to this embodiment, reducing the gain of gain controlled amplifier 114. In a similar, but opposite fashion, the gain control signal line 112 may have a control signal that starts at the beginning of the time period T at a minimum voltage thereby, according to this embodiment, setting the gain of the gain controlled amplifier 116 to a minimum, and as the time period T proceeds, the control signal on the gain control signal line 112 increases until it is at a maximum voltage, thereby, according to this embodiment, increasing the gain of the gain controlled amplifier 116.
Since the outputs of the voltage-to-current converters 122 and 124 may be in parallel, the output current 126 may represent the dominant gain controlled amplifier output signal 118 or 120, e.g., the one having the highest gain and signal input will block the other one. Thus, according to this embodiment, input signals 102 and 108 may be switched without introducing a transient in the output current signal 126. The output current signal 126 may be used to supply sensor information to an oximeter 212, e.g., oximeter display monitor. The timing and clocking circuit 228 may be used for clock signals and timing signals for the light emitting diodes 230 and the controller 216.
While embodiments of this disclosure have been depicted, described, and are defined by reference to example embodiments of the disclosure, such references do not imply a limitation on the disclosure, and no such limitation is to be inferred. The subject matter disclosed is capable of considerable modification, alteration, and equivalents in form and function, as will occur to those ordinarily skilled in the pertinent art and having the benefit of this disclosure. The depicted and described embodiments of this disclosure are examples only, and are not exhaustive of the scope of the disclosure.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3638640 | Shaw | Feb 1972 | A |
| 4714341 | Hamaguri et al. | Dec 1987 | A |
| 4800885 | Johnson | Jan 1989 | A |
| 4805623 | Jöbsis | Feb 1989 | A |
| 4807631 | Hersh et al. | Feb 1989 | A |
| 4819646 | Cheung et al. | Apr 1989 | A |
| 4846183 | Martin | Jul 1989 | A |
| 4911167 | Corenman et al. | Mar 1990 | A |
| 4913150 | Cheung et al. | Apr 1990 | A |
| 4936679 | Mersch | Jun 1990 | A |
| 4938218 | Goodman et al. | Jul 1990 | A |
| 4971062 | Hasebe et al. | Nov 1990 | A |
| 4972331 | Chance | Nov 1990 | A |
| 4974591 | Awazu et al. | Dec 1990 | A |
| 5028787 | Rosenthal et al. | Jul 1991 | A |
| 5065749 | Hasebe et al. | Nov 1991 | A |
| 5084327 | Stengel | Jan 1992 | A |
| 5119815 | Chance | Jun 1992 | A |
| 5122974 | Chance | Jun 1992 | A |
| 5167230 | Chance | Dec 1992 | A |
| 5190038 | Polson et al. | Mar 1993 | A |
| 5246003 | DeLonzor | Sep 1993 | A |
| 5247931 | Norwood | Sep 1993 | A |
| 5263244 | Centa et al. | Nov 1993 | A |
| 5275159 | Griebel | Jan 1994 | A |
| 5279295 | Martens et al. | Jan 1994 | A |
| 5297548 | Pologe | Mar 1994 | A |
| 5348004 | Hollub | Sep 1994 | A |
| 5355880 | Thomas et al. | Oct 1994 | A |
| 5372136 | Steuer et al. | Dec 1994 | A |
| 5385143 | Aoyagi | Jan 1995 | A |
| 5390670 | Centa et al. | Feb 1995 | A |
| 5413099 | Schmidt et al. | May 1995 | A |
| 5469845 | DeLonzor et al. | Nov 1995 | A |
| 5482036 | Diab et al. | Jan 1996 | A |
| 5483646 | Uchikoga | Jan 1996 | A |
| 5553614 | Chance | Sep 1996 | A |
| 5564417 | Chance | Oct 1996 | A |
| 5575285 | Takanashi et al. | Nov 1996 | A |
| 5611337 | Bukta | Mar 1997 | A |
| 5630413 | Thomas et al. | May 1997 | A |
| 5645059 | Fein et al. | Jul 1997 | A |
| 5645060 | Yorkey | Jul 1997 | A |
| 5680857 | Pelikan et al. | Oct 1997 | A |
| 5692503 | Keunstner | Dec 1997 | A |
| 5730124 | Yamauchi | Mar 1998 | A |
| 5758644 | Diab et al. | Jun 1998 | A |
| 5779631 | Chance | Jul 1998 | A |
| 5782757 | Diab et al. | Jul 1998 | A |
| 5786592 | Hök | Jul 1998 | A |
| 5830136 | DeLonzor et al. | Nov 1998 | A |
| 5830139 | Abreu | Nov 1998 | A |
| 5842981 | Larsen et al. | Dec 1998 | A |
| 5871442 | Madarasz et al. | Feb 1999 | A |
| 5873821 | Chance et al. | Feb 1999 | A |
| 5995856 | Mannheimer et al. | Nov 1999 | A |
| 6011986 | Diab et al. | Jan 2000 | A |
| 6064898 | Aldrich | May 2000 | A |
| 6081742 | Amano et al. | Jun 2000 | A |
| 6088607 | Diab et al. | Jul 2000 | A |
| 6120460 | Abreu | Sep 2000 | A |
| 6134460 | Chance | Oct 2000 | A |
| 6150951 | Olejniczak | Nov 2000 | A |
| 6154667 | Miura et al. | Nov 2000 | A |
| 6163715 | Larsen et al. | Dec 2000 | A |
| 6181958 | Steuer et al. | Jan 2001 | B1 |
| 6181959 | Schöllermann et al. | Jan 2001 | B1 |
| 6230035 | Aoyagi et al. | May 2001 | B1 |
| 6266546 | Steuer et al. | Jul 2001 | B1 |
| 6285895 | Ristolainen et al. | Sep 2001 | B1 |
| 6312393 | Abreu | Nov 2001 | B1 |
| 6353750 | Kimura et al. | Mar 2002 | B1 |
| 6397091 | Diab et al. | May 2002 | B2 |
| 6415236 | Kobayashi et al. | Jul 2002 | B2 |
| 6419671 | Lemberg | Jul 2002 | B1 |
| 6438399 | Kurth | Aug 2002 | B1 |
| 6461305 | Schnall | Oct 2002 | B1 |
| 6466809 | Riley | Oct 2002 | B1 |
| 6487439 | Skladnev et al. | Nov 2002 | B1 |
| 6501974 | Huiku | Dec 2002 | B2 |
| 6501975 | Diab et al. | Dec 2002 | B2 |
| 6526301 | Larsen et al. | Feb 2003 | B2 |
| 6544193 | Abreu | Apr 2003 | B2 |
| 6546267 | Sugiura et al. | Apr 2003 | B1 |
| 6549795 | Chance | Apr 2003 | B1 |
| 6580086 | Schulz et al. | Jun 2003 | B1 |
| 6591122 | Schmitt | Jul 2003 | B2 |
| 6594513 | Jobsis et al. | Jul 2003 | B1 |
| 6606509 | Schmitt | Aug 2003 | B2 |
| 6615064 | Aldrich | Sep 2003 | B1 |
| 6622095 | Kobayashi et al. | Sep 2003 | B2 |
| 6654621 | Palatnik et al. | Nov 2003 | B2 |
| 6658277 | Wasserman | Dec 2003 | B2 |
| 6662030 | Khalil et al. | Dec 2003 | B2 |
| 6671526 | Aoyagi et al. | Dec 2003 | B1 |
| 6671528 | Steuer et al. | Dec 2003 | B2 |
| 6678543 | Diab et al. | Jan 2004 | B2 |
| 6690958 | Walker et al. | Feb 2004 | B1 |
| 6708048 | Chance | Mar 2004 | B1 |
| 6711424 | Fine et al. | Mar 2004 | B1 |
| 6711425 | Reuss | Mar 2004 | B1 |
| 6785568 | Chance | Aug 2004 | B2 |
| 6793654 | Lemberg | Sep 2004 | B2 |
| 6801797 | Mannheimer et al. | Oct 2004 | B2 |
| 6801798 | Geddes et al. | Oct 2004 | B2 |
| 6801799 | Mendelson | Oct 2004 | B2 |
| 6829496 | Nagai et al. | Dec 2004 | B2 |
| 6873865 | Steuer et al. | Mar 2005 | B2 |
| 6889153 | Dietiker | May 2005 | B2 |
| 6896661 | Dekker et al. | May 2005 | B2 |
| 6939307 | Dunlop | Sep 2005 | B1 |
| 6949081 | Chance | Sep 2005 | B1 |
| 6961598 | Diab | Nov 2005 | B2 |
| 6983178 | Fine et al. | Jan 2006 | B2 |
| 6996427 | Ali et al. | Feb 2006 | B2 |
| 7001337 | Dekker et al. | Feb 2006 | B2 |
| 7024233 | Ali et al. | Apr 2006 | B2 |
| 7024235 | Melker et al. | Apr 2006 | B2 |
| 7027849 | Al-Ali | Apr 2006 | B2 |
| 7035697 | Brown | Apr 2006 | B1 |
| 7047056 | Hannula et al. | May 2006 | B2 |
| 7127278 | Melker et al. | Oct 2006 | B2 |
| 7130671 | Baker, Jr. et al. | Oct 2006 | B2 |
| 7162288 | Nordstrom et al. | Jan 2007 | B2 |
| 7209775 | Bae et al. | Apr 2007 | B2 |
| 7236811 | Schmitt | Jun 2007 | B2 |
| 7263395 | Chan et al. | Aug 2007 | B2 |
| 7267652 | Coyle et al. | Sep 2007 | B2 |
| 7272426 | Schmid | Sep 2007 | B2 |
| 7440788 | Jenkins et al. | Oct 2008 | B2 |
| 20010005773 | Larsen et al. | Jun 2001 | A1 |
| 20010020122 | Steuer et al. | Sep 2001 | A1 |
| 20010039376 | Steuer et al. | Nov 2001 | A1 |
| 20010044700 | Kobayashi et al. | Nov 2001 | A1 |
| 20020026106 | Khalil et al. | Feb 2002 | A1 |
| 20020035318 | Mannheimer et al. | Mar 2002 | A1 |
| 20020038079 | Steuer et al. | Mar 2002 | A1 |
| 20020042558 | Mendelson | Apr 2002 | A1 |
| 20020049389 | Abreu | Apr 2002 | A1 |
| 20020062071 | Diab et al. | May 2002 | A1 |
| 20020111748 | Kobayashi et al. | Aug 2002 | A1 |
| 20020133068 | Huiku | Sep 2002 | A1 |
| 20020156354 | Larson | Oct 2002 | A1 |
| 20020161287 | Schmitt | Oct 2002 | A1 |
| 20020161290 | Chance | Oct 2002 | A1 |
| 20020165439 | Schmitt | Nov 2002 | A1 |
| 20020198443 | Ting | Dec 2002 | A1 |
| 20030023140 | Chance | Jan 2003 | A1 |
| 20030055324 | Wasserman | Mar 2003 | A1 |
| 20030060693 | Monfre et al. | Mar 2003 | A1 |
| 20030139687 | Abreu | Jul 2003 | A1 |
| 20030141914 | Buchwald et al. | Jul 2003 | A1 |
| 20030144584 | Mendelson | Jul 2003 | A1 |
| 20030220548 | Schmitt | Nov 2003 | A1 |
| 20030220576 | Diab | Nov 2003 | A1 |
| 20040010188 | Wasserman | Jan 2004 | A1 |
| 20040054270 | Pewzner et al. | Mar 2004 | A1 |
| 20040087846 | Wasserman | May 2004 | A1 |
| 20040107065 | Al-Ali | Jun 2004 | A1 |
| 20040127779 | Steuer et al. | Jul 2004 | A1 |
| 20040163648 | Burton | Aug 2004 | A1 |
| 20040171920 | Mannheimer et al. | Sep 2004 | A1 |
| 20040176670 | Takamura et al. | Sep 2004 | A1 |
| 20040176671 | Fine et al. | Sep 2004 | A1 |
| 20040230106 | Schmitt et al. | Nov 2004 | A1 |
| 20050080323 | Kato | Apr 2005 | A1 |
| 20050085735 | Baker, Jr. et al. | Apr 2005 | A1 |
| 20050101850 | Parker | May 2005 | A1 |
| 20050105554 | Kagan et al. | May 2005 | A1 |
| 20050107676 | Acosta et al. | May 2005 | A1 |
| 20050113656 | Chance | May 2005 | A1 |
| 20050159646 | Nordstrom et al. | Jul 2005 | A1 |
| 20050168722 | Forstner et al. | Aug 2005 | A1 |
| 20050177034 | Beaumont | Aug 2005 | A1 |
| 20050192488 | Bryenton et al. | Sep 2005 | A1 |
| 20050203357 | Debreczeny et al. | Sep 2005 | A1 |
| 20050228248 | Dietiker | Oct 2005 | A1 |
| 20050267346 | Faber et al. | Dec 2005 | A1 |
| 20050283059 | Iyer et al. | Dec 2005 | A1 |
| 20060009688 | Lamego et al. | Jan 2006 | A1 |
| 20060015021 | Cheng | Jan 2006 | A1 |
| 20060020181 | Schmitt | Jan 2006 | A1 |
| 20060030763 | Mannheimer et al. | Feb 2006 | A1 |
| 20060052680 | Diab | Mar 2006 | A1 |
| 20060058683 | Chance | Mar 2006 | A1 |
| 20060064024 | Schnall | Mar 2006 | A1 |
| 20060195025 | Ali et al. | Aug 2006 | A1 |
| 20060195028 | Hannula et al. | Aug 2006 | A1 |
| 20060224058 | Mannheimer | Oct 2006 | A1 |
| 20060247501 | Ali | Nov 2006 | A1 |
| 20060258921 | Addison et al. | Nov 2006 | A1 |
| 20070208240 | Nordstrom et al. | Sep 2007 | A1 |
| 20080082018 | Sackner et al. | Apr 2008 | A1 |
| 20080287757 | Berson et al. | Nov 2008 | A1 |
| Number | Date | Country |
|---|---|---|
| 102 13 692 | Oct 2003 | DE |
| 2237544 | Sep 1990 | JP |
| 3170866 | Jul 1991 | JP |
| 4332536 | Nov 1992 | JP |
| 5-212016 | Aug 1993 | JP |
| 3238813 | Oct 1994 | JP |
| 8256996 | Oct 1996 | JP |
| 2003194714 | Jul 2003 | JP |
| 2003210438 | Jul 2003 | JP |
| 2004008572 | Jan 2004 | JP |
| 2004113353 | Apr 2004 | JP |
| 2004194908 | Jul 2004 | JP |
| 2004248819 | Sep 2004 | JP |
| 2004290545 | Oct 2004 | JP |
| WO 9220273 | Nov 1992 | WO |
| WO9309711 | May 1993 | WO |
| WO 9403102 | Feb 1994 | WO |
| W09512349 | May 1995 | WO |
| WO 9749330 | Dec 1997 | WO |
| WO9843071 | Oct 1998 | WO |
| WO9932030 | Jul 1999 | WO |
| WO0021438 | Apr 2000 | WO |
| WO 0145553 | Jun 2001 | WO |
| W02006100685 | Sep 2006 | WO |
| Number | Date | Country | |
|---|---|---|---|
| 20080081970 A1 | Apr 2008 | US |